Kyverna Therapeutics, Inc. · Brief

Next report

11 days

Nov 11 · after closeest.Q3 FY26

Expected move

±24.0%implied · straddle

4.317.03

spot 5.67exp Nov 20ATM strike 5ATM straddle 1.60IV 147%

Oct 30 close

Expected move

—≥ implied

Q2 FY26±15.9%▲+0.37%×0.02

quarterimplied−20%0+20%realized×

Q2 FY26±15.9%▲+0.37%×0.02

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 11 report · est.

Bull2

120managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+15.15%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

6 of 25of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

19managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

KYTX report session

No linked exposure.

Oct 28impliedImplied move: ±22.7% into Nov 11 earnings (Oct 28 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.